SKYSTAR BIO-PHARMACEUTICAL CO Proceeds from Short-term Debt
SKYSTAR BIO-PHARMACEUTICAL CO reported Proceeds from Short-term Debt of $19.20 million for the 9-month period ending 2014-09-30, per its 10-Q filed 2014-11-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromShortTermDebt · last filed 2014-11-14
- SKYSTAR BIO-PHARMACEUTICAL CO proceeds from short-term debt for the quarter ending 2014-09-30 was $1.61M, a 2.25% decline year-over-year.
- SKYSTAR BIO-PHARMACEUTICAL CO proceeds from short-term debt for the quarter ending 2014-06-30 was $17.59M, a 335.87% increase year-over-year.
- SKYSTAR BIO-PHARMACEUTICAL CO proceeds from short-term debt for the quarter ending 2014-03-31 was $0.00, a 100.00% decline year-over-year.
- SKYSTAR BIO-PHARMACEUTICAL CO proceeds from short-term debt for the quarter ending 2013-12-31 was $38.35K, a 96.98% decline year-over-year.
- SKYSTAR BIO-PHARMACEUTICAL CO proceeds from short-term debt for fiscal 2013 was $10.50M, a 81.84% increase from fiscal 2012.
- SKYSTAR BIO-PHARMACEUTICAL CO proceeds from short-term debt for fiscal 2012 was $5.77M, a 46.81% decline from fiscal 2011.
- SKYSTAR BIO-PHARMACEUTICAL CO proceeds from short-term debt for fiscal 2011 was $10.86M, a 297.82% increase from fiscal 2010.
- SKYSTAR BIO-PHARMACEUTICAL CO proceeds from short-term debt for fiscal 2010 was $2.73M.
| Period end | Proceeds from Short-term Debt 3 month | Proceeds from Short-term Debt 6 month | Proceeds from Short-term Debt 9 month | Proceeds from Short-term Debt 12 month |
|---|---|---|---|---|
| 2014-09-30 | $1.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $19.20M derived: sum of 2 quarters · filed 2014-11-14 | $19.20M 10-Q · filed 2014-11-14 | $19.24M derived: sum of 4 quarters · filed 2014-11-14 |
| 2014-06-30 | $17.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $17.59M 10-Q · filed 2014-08-14 | $17.63M derived: sum of 3 quarters · filed 2014-08-14 | $19.28M derived: sum of 4 quarters · filed 2014-11-14 |
| 2014-03-31 | $0.00 10-Q · filed 2014-05-15 | $38.35K derived: sum of 2 quarters · filed 2014-05-15 | $1.69M derived: sum of 3 quarters · filed 2014-11-14 | $5.72M derived: sum of 4 quarters · filed 2014-11-14 |
| 2013-12-31 | $38.35K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $1.69M derived: sum of 2 quarters · filed 2014-11-14 | $5.72M derived: sum of 3 quarters · filed 2014-11-14 | $10.50M 10-K · filed 2014-03-31 |
| 2013-09-30 | $1.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $5.68M derived: sum of 2 quarters · filed 2014-11-14 | $10.46M 10-Q · filed 2014-11-14 | $11.73M derived: sum of 4 quarters · filed 2014-11-14 |
| 2013-06-30 | $4.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $8.82M 10-Q · filed 2014-08-14 | $10.09M derived: sum of 3 quarters · filed 2014-08-14 | $14.53M derived: sum of 4 quarters · filed 2014-08-14 |
| 2013-03-31 | $4.78M 10-Q · filed 2014-05-15 | $6.05M derived: sum of 2 quarters · filed 2014-05-15 | $10.49M derived: sum of 3 quarters · filed 2014-05-15 | $10.49M derived: sum of 4 quarters · filed 2014-05-15 |
| 2012-12-31 | $1.27M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $5.71M derived: sum of 2 quarters · filed 2014-03-31 | $5.71M derived: sum of 3 quarters · filed 2014-03-31 | $5.77M 10-K · filed 2014-03-31 |
| 2012-09-30 | $4.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $4.44M derived: sum of 2 quarters · filed 2013-11-14 | $4.50M 10-Q · filed 2013-11-14 | $12.08M derived: sum of 4 quarters · filed 2013-11-14 |
| 2012-06-30 | -$56.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $63.46K 10-Q · filed 2013-08-14 | $7.64M derived: sum of 3 quarters · filed 2013-08-14 | $9.20M derived: sum of 4 quarters · filed 2013-08-14 |
| 2012-03-31 | $63.52K 10-Q · filed 2013-05-15 | $7.64M derived: sum of 2 quarters · filed 2013-05-15 | $9.20M derived: sum of 3 quarters · filed 2013-05-15 | $9.66M derived: sum of 4 quarters · filed 2013-05-15 |
| 2011-12-31 | $7.58M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | $9.13M derived: sum of 2 quarters · filed 2012-11-14 | $9.60M derived: sum of 3 quarters · filed 2012-11-14 | $10.86M 10-K · filed 2012-03-30 |
| 2011-09-30 | $1.55M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-14 | $2.02M derived: sum of 2 quarters · filed 2012-11-14 | $3.28M 10-Q · filed 2012-11-14 | $4.21M derived: sum of 4 quarters · filed 2012-11-14 |
| 2011-06-30 | $467.01K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-09-13 | $1.72M 10-Q/A · filed 2012-09-13 | $2.65M derived: sum of 3 quarters · filed 2012-09-13 | $4.45M derived: sum of 4 quarters · filed 2012-09-13 |
| 2011-03-31 | $1.26M 10-Q · filed 2012-05-15 | $2.19M derived: sum of 2 quarters · filed 2012-05-15 | $3.99M derived: sum of 3 quarters · filed 2012-05-15 | |
| 2010-12-31 | $929.35K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | $2.73M derived: sum of 2 quarters · filed 2012-03-30 | $2.73M 10-K · filed 2012-03-30 | |
| 2010-09-30 | $1.80M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-14 | $1.80M 10-Q · filed 2011-11-14 | ||
| 2010-06-30 | $0.00 10-Q/A · filed 2011-09-21 |